Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Dermira Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Dermira (DERM) Prices 9.81M Shares Common Offering at $13.25/Sh
-
Dermira Prices $130.0 Million Public Offering of Common Stock
-
Dermira (DERM) Plans Public Offering of Common Stock
-
Dermira Announces Proposed Public Offering of Common Stock
-
Dermira's (DERM) Almirall Partnership Reduces Cash Burn While Validating Lebrikizumab - Cantor
-
Dermira (DERM) Moving Ahead on All Commercial Efforts Says Cantor
-
Dermira (DERM): FDA Approval of Qbrexza is Positive and Co. is Well Funded Through Launch - Cantor Fitzgerald
-
Dermira (DERM) PT Lowered to $20 at Cantor Fitzgerald
-
Dermira to Present at Cantor Fitzgerald Global Healthcare Conference
-
UPDATE: Cantor Fitzgerald Starts Dermira (DERM) at Overweight
-
Pre-Open Stock Movers 06/02: (BWEN) (RPRX) (CIEN) Higher; (CONN) (SRPT) (DV) Lower (more...)

